🇫🇷 Novacyt
ALNOV.PAFundamentals
Gross Margin
38.7%
Op. Margin
-64.6%
Net Margin
-10.5%
ROIC
-234.9%
Rev Growth
3.9%
Valuation
Price
0.50 EUR
Day
-1.96%
52-Week Range
0.29 - 1.04
Market Cap
36M EUR
Fwd P/E
1.9x
EV/EBITDA
10.5x
Div Yield
-
Annual income statement #
Novacyt annual revenue, operating income and net income in EUR, 2016 to 2025. Revenue was 20.4m in 2025.
| Year | Revenue (EUR) | Operating income | Net income | Net margin |
|---|---|---|---|---|
| 2025 | 20.4m | -13.2m | -23.3m | |
| 2024 | 19.6m | -37.3m | -41.8m | |
| 2023 | 11.6m | -29.5m | -28.3m | |
| 2022 | 21.0m | -23.4m | -25.7m | |
| 2021 | 92.6m | -3.9m | -9.7m | -10.5% |
| 2020 | 277.2m | 167.4m | 132.4m | 47.8% |
| 2019 | 13.1m | -1.2m | -6.6m | -50.1% |
| 2018 | 13.7m | -308,000 | -4.7m | -34.5% |
| 2017 | 12.7m | -122,000 | -4.8m | -37.9% |
| 2016 | 11.1m | -3.0m | -4.9m | -44.0% |
Financial Data #
Segment Breakdown #
Peers #
ALKLH.PA BCART.BR PANG.MC NN6.DE ALBIO.PA BIOPOR.CO SCP.WA SENZA.ST SLV.WA BOUL.ST ·
Compare in Screener
Dividends
Bubble
Events #
| Date | Type | Details | Price | Amount |
|---|